-
Direct Medical Costs of Home-Based Respiratory Support and Oxygen Therapy for Patients With Chronic Respiratory Failure
Sep 9, 2025, 16:22 PM -
HTA Readiness for Tumor-Agnostic Therapies: Lessons From Analogues Across Major Markets
Sep 9, 2025, 16:22 PM -
Cost-Minimization Analysis and Economic Impact in EGPA: Evidence From MANDARA
Sep 9, 2025, 16:22 PM -
Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework
Sep 9, 2025, 16:22 PM -
Epidemiological Burden of Osteoarthritis in Eastern, Central, and Western Europe Between 1990 and 2021
Sep 9, 2025, 16:22 PM -
Clinical Benefit vs. Reimbursement Decisions: Examining Misalignments Between ESMO-MCBS and HTA Outcomes in Oncology
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Impact of Nirmatrelvir/Ritonavir in Reducing Hospitalizations Among Elderly COVID-19 Patients in Sweden
Sep 9, 2025, 16:22 PM -
The Clinical Impact of Screening Blood Donations for Hepatitis E Virus in Catalonia
Sep 9, 2025, 16:22 PM -
CAR-NK Cell Therapy for Ovarian Cancer Treatment in the First Relapse: Assessing Conditions Needed for Cost-Effectiveness in the Netherlands Using Early Health-Economic Modeling
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Ocrelizumab for Treating Relapsing Multiple Sclerosis in Austria
Sep 9, 2025, 16:22 PM -
Premature Mortality and Lost Productivity Due to HPV-Related Cancers in Europe
Sep 9, 2025, 16:22 PM -
The Long-Term Cost-Effectiveness of Insulin Icodec vs. Once-Daily Basal Insulin Analogs in Italy
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Balancing Fit and Accuracy: Evaluating Survival Model Projections With Immature Data in Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Assessment of the Cost Utility of Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Preterm Infants Born 29-35 Weeks' Gestational Age in the Philippines
Sep 9, 2025, 16:22 PM -
Director Primary Data Collection
Sep 9, 2025, 16:22 PM -
Beyond the Guidelines: Exploring the Characteristics and Comorbidity Profiles of Adults With Pneumococcal Disease in England Not Covered by Current Pneumococcal Vaccination Criteria
Sep 9, 2025, 16:22 PM -
Years of Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Ukraine and in Kiev City, Lviv, and Cherkasy Regions
Sep 9, 2025, 16:22 PM -
OncoLlama: Quantifying Cancer Inequalities at Population Scale Using Large Language Models for Clinical Text Abstraction
Sep 9, 2025, 16:22 PM -
Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review
Sep 9, 2025, 16:22 PM
